TAP returns Spectracef rights
Executive Summary
TAP returns Spectracef (ceftidoren) rights to Japan-based Meiji Seika Kaisha. The cephalosporin antibiotic was approved Aug. 29, 2001 for treatment of acute exacerbation of chronic bronchitis, pharyngitis/tonsillitis, and uncomplicated skin and skin structure infections (1"The Pink Sheet" Sept. 1, 2003, p. 20)...